DNA becomes primary target in fight against glioblastoma

July 21, 2017 by Chrystian Tejedor, Florida International University
Credit: Florida International University

By exploiting a brain tumor's own biology, researchers at FIU's Biomolecular Sciences Institute (BSI) are hoping to destroy glioblastoma, a deadly brain cancer with no known cure.

Current methods of treatment are complicated and while they can only prolong a patient's life by a few months, they cannot cure the cancer—a reality many Americans are becoming aware of following the recent diagnosis for former presidential candidate and U.S. Sen. John McCain. It would be ideal if current treatments worked well for everyone, but when a cancer patient is undergoing radiation or , the tumors are fighting for their own life, according to BSI Director Yuk-Ching Tse-Dinh, a professor of Chemistry and Biochemistry in the College of Arts, Sciences & Education.

The BSI team is working on a two-pronged method of stamping out the tumor. Tse-Dinh and Chemistry and Biochemistry associate professor Yuan Liu are trying to inhibit the tumor from repairing its own DNA. Liu points out that tumors have evolved over time to boost their DNA repair in an effort to stave off the damage inflicted with radiation or chemotherapy. The researchers hope they can make existing drugs more effective in destroying a glioblastoma tumor with this approach.

Jeremy W. Chambers, an assistant professor of Environmental and Occupational Health in the Robert Stempel College of Public Health and Social Work, is studying whether changes in mitochondria, the powerhouses of a cell, can trick cancer cells into entering the pathway toward .

"We're looking at this from multiple angles," Tse-Dinh said. "We want to understand the factors that determine the tumor's overall response to chemotherapy or whether a particular patient may be more responsive to a particular therapy or regiment."

Ultimately, if a tumor has to dedicate resources to fighting the damage in its own genome or undergo programmed cell death, researchers hope they can bring an end to glioblastoma's aggressive attack on the brain.

Today, current treatment involves surgical removal of as much of the tumor as possible, followed by radiation and drugs to attack whatever remains. But glioblastoma is very difficult to treat and radiation and chemotherapy are particularly hard on patients.

"Think of it as an octopus with a central body and tendrils that project into the brain. Then imagine being a surgeon trying to remove the and all these projections," Chambers said.

With the new approaches being investigated by the BSI team, the researchers hope to reduce the toxic effects of chemotherapy and improve the outcome of glioblastoma treatment.

Explore further: Identification of PTPRZ as a drug target for cancer stem cells in glioblastoma

Related Stories

Identification of PTPRZ as a drug target for cancer stem cells in glioblastoma

July 19, 2017
Glioblastoma is a malignant brain tumor with high mortality. Cancer stem cells are thought to be crucial for tumor initiation and its recurrence after standard therapy with radiation and temozolomide (TMZ) chemotherapy. Protein ...

Glioblastoma 'ecosystem' redefined for more effective immunotherapy trials

July 10, 2017
A research team has revealed the intrinsic gene expression patterns of glioblastoma (GBM) tumors, insights that could drive more effective treatments for GBM, the most common and deadly malignant primary brain tumors in adults.

Using a microRNA to shift the makeup of glioblastoma subtypes

July 13, 2017
Glioblastoma multiforme (GBM), an extremely aggressive brain cancer, is a very complex disease. It is characterized by a fast-growing tumor in the brain composed of many subpopulations of cells, including glioblastoma stem ...

Study finds new targets for drugs to defeat aggressive brain tumor

December 14, 2012
University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy ...

Researchers find new driver of an aggressive form of brain cancer

November 15, 2016
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age. The discovery can help researchers ...

Recommended for you

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Cave_Man
not rated yet Jul 23, 2017
How about Sulphorane (from broccoli) and DMSO. Sulphorane is extremely toxic to brain cancer cells, triggering apoptosis very well, but it has poor transport across the blood brain barrier. Di-Methyl Sulfoxide or DMSO absorbs through the skin and has VERY high transport potential across BBB...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.